UNSPSC 51302102: Triafungin

This classification denotes an antifungal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E51A927SNR. European Medicines Agency schedules Triafungin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11250MIG. Triafungin generally arises in the molecular formula C13H10N4. The term TRIAFUNGIN is an International Non-Proprietary Name or INN. TRIAFUNGIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule triafungin under HS 29339990 and SITC 51577. As of Q4 2014, TRIAFUNGIN remains the US FDA Preferred Term for this commodity. Triafungin bears US NLM identifiers UMLS ID C2348816 and NCI Concept Code C72965. SMILES: N1C(NNC2C1CNCC2)CC1CCCCC1.

UNSPSC 51302102 Triafungin (Commodity) represents a specialized pharmaceutical category, though recent state and local procurement activity under this code shows minimal relevant solicitations. The single opportunity identified—the City of Tampa Fire Rescue Department's ITB 25-P-00157 for medical aid supplies—covers a broad array of first aid and emergency medical items including antiseptic sprays, hydrogen peroxide, pain relievers, and bandages, with no specific mention of triafungin or antifungal medications as a distinct line item. The scope encompasses 32 medical and first aid supply items with estimated annual quantities ranging from 1 to 2,700 units per item, suggesting the procurement is structured to accommodate both high-volume consumables and lower-quantity specialized products across a single award mechanism.

The City of Tampa Fire Rescue Department issued this ITB with a bid opening date of April 9, 2025, and a total department budget of $100,000 for the procurement period. The solicitation includes set-aside provisions for City-certified Small Local Business Enterprises and Underutilized Woman and Minority Owned Business Enterprises, with bid discounts capped at $10,000 for SLBEs and $20,000 for U-WMBEs. The contract structure allows for an initial one-year award period with two additional one-year renewal options. All medications must maintain a minimum nine-month expiration date from the date of acceptance. The solicitation does not reflect concentrated activity under this Commodity code across multiple issuing bodies or states; Tampa represents the only documented recent opportunity with explicit reference to this UNSPSC classification.